PEPTIDES: SCIENCE OR SNAKE OIL?

One person's miracle can be another person's mistake. Is the rise of peptides little more than a story of shortcut culture meeting grift economics?

A few years ago, most people in fitness were arguing about protein powder and creatine.

Now it’s peptides.

Everyone’s suddenly “looking into peptides”. Recovery peptides. Healing peptides. Longevity peptides. It all sounds advanced, precise, scientific. But here’s the problem:

The word peptide, on its own, tells you almost nothing.

A peptide is just a short chain of amino acids and there are thousands of them. So saying something is “a peptide” tells you almost nothing about what it actually does. It doesn’t tell you whether it affects appetite, hormones, inflammation, recovery, or nothing useful at all.

Yet in modern fitness culture, the word has somehow become shorthand for advanced, elite, optimised, cutting-edge. That’s where things start to drift.

⸻

“Peptide” is a category, not a function and this is the key misunderstanding.

People hear the word and assume it refers to a specific type of effect, usually something to do with recovery or performance. It doesn't. It’s just a broad category. Like the word "medication". That word tells you nothing on its own. Some medications reduce pain, others lower blood pressure, others affect mood. The category is broad, the effects are specific. Peptides are exactly the same.

GLP-1 is a peptide. That should make people pause.

This is where the misunderstanding becomes clearer, because GLP-1 is far removed from how people usually view peptides.

And when people talk about GLP-1, they’re usually referring to drugs like Ozempic, Wegovy, or Mounjaro - medications that affect appetite, blood sugar, and body weight. The bizarre thing is, although they sit in the same broad GLP-1 family, the 3 names I just mentioned, are not the same. They differ in dose, in trial data, and for what outcomes they are approved.

So despite being a peptide class with the most robust clinical trial data, one drug is approved for type 2 diabetes, another for obesity, another for sleep apnoea, some for children/adolescents, while others are still adult-only. If all this is true of the GLP-1 family, imagine the gauntlet you are running trusting less understood peptide groups.

Retatrutide: Real science already drifitng off into fantasy

If you’ve spent any time in peptide circles, you’ve probably seen retatrutide pitched as the “next-generation GLP-1”. Stronger fat loss, better body composition, less muscle loss. The upgrade. The cheat code.

So this is where it gets interesting: retatrutide isn’t fake. It’s a real drug in development that acts on GLP-1, GIP, and glucagon receptors. A triple-agonist designed to influence appetite, metabolism, and energy expenditure all at once. Early trial data suggest it may drive very significant weight loss, potentially more than current GLP-1 drugs.

So far, so good.

But here’s where peptide culture does what it always does: it takes something early, incomplete, and still being studied, and sells it like it’s fully understood. Suddenly retatrutide isn’t just promising, it’s being framed as the solution to everything GLP-1 “got wrong”. Less muscle loss. Better fat loss. Superior results.

That’s the leap.

Because we don’t yet have long-term, real-world data showing how this plays out across different people, training styles, or body compositions. And even if it does preserve slightly more lean mass on paper, that doesn’t override the basics: if you’re losing weight aggressively without resistance training and adequate protein, you will lose muscle.

The pattern is the same for all peptides in the wellness sphere, whether they promise

healing, recovery, muscle, anti-ageing or even tanning (yep). In many cases there's so little trial data that we are effectively taking a stab-in-the-dark in terms of the side effects of long term use and withdrawal. Yet, theres a thriving grey market for these products.

⸻

One person’s miracle can be another person’s mistake

People respond differently.

That’s not controversial. That’s basic biology. Peptides don't work inside a vacuum.

Like any compound, they interact with your physiology and genetics, your hormone profile, your training load, your diet, your sleep, stress, and health. So yes, the same peptide could be both helpful for one person, irrelevant for another and actively unhelpful for someone else.

We know people are different, the real question is:

Can we actually predict those differences reliably?

For a lot of the compounds being discussed online, the honest answer is:

Not nearly as confidently as the internet pretends.

Mechanism is not the same as outcome

This is where a lot of people get misled.

They hear: “supports healing” “targets inflammation” “affects growth hormone”

…and assume the outcome must be positive.

Biology doesn’t guarantee that. Even if something influences a pathway, that doesn’t automatically mean it improves performance, recovery, or long-term health. What matters is what happens in real humans, at real doses, over real time, with real trade-offs....The horrors of which are not limited to your imagination. This is literally why clinical trials exist.

That’s a much higher bar than most conversations reach. For many of the peptides floating around fitness and “performance” culture, the evidence base is often a mix of early-stage research, small or short-term studies, anecdote and marketing dressed up as science.

That doesn’t mean nothing works. But it does mean a lot of people are operating with far more confidence than the evidence supports.

Most people don’t have a peptide problem

They have a basics problem.

Not enough muscle. Poor sleep. Inconsistent training. Too much intensity, not enough progression. Constantly changing direction. Poor food choices.

That’s where most performance issues actually come from, and where most true improvements happen.

But those problems are slow, unglamorous, and require patience.

Peptides sound like a shortcut. That’s the real appeal.

This I believe is the bigger issue. The peptide trend isn’t really about peptides.

It’s about people wanting the language of high performance without the behaviour of high performance.

Talking about compounds, pathways, and protocols feels advanced.

Doing the basics properly, repeatedly, for long enough to matter… doesn’t.

But, again, that’s still where almost all real progress comes from. Champions know this.

⸻

Final thought

The problem with peptide culture isn’t scientific curiosity, nor the desire to be better.

It’s confidence without enough evidence. A peptide might help one person, do nothing for another, and be actively detrimental to a third, and in many cases we don’t yet have enough data to know which group you’re in before you start.

For me, it looks like this: A promising but easily misunderstood niche of science has yet again been hijacked by online grifters exploiting the shortcut culture of a low-attention-span society.

For a few special populations, they may well be a saviour. For the majority of the public, peptides are the human equivalent of trying to tune an engine that's been running on dog-shit and bad decisions.

-Craig

.